Share via:
GLP-1 agonists—so-called “wonder drugs” like Ozempic or Wegovy that help individuals lower blood sugar levels and lose weight, among other things—yield significant results for some patients, but not all. People’s motivations to overeat may play a role in this, according to a new study.
To investigate why some people don’t benefit from GLP-1 agonists as much as others, researchers observed 92 participants with type 2 diabetes in Japan during their…
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
GLP-1 agonists—so-called “wonder drugs” like Ozempic or Wegovy that help individuals lower blood sugar levels and lose weight, among other things—yield significant results for some patients, but not all. People’s motivations to overeat may play a role in this, according to a new study.
To investigate why some people don’t benefit from GLP-1 agonists as much as others, researchers observed 92 participants with type 2 diabetes in Japan during their…
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi
